Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings

Abstract

Background We evaluated the clinicopathologic characteristics and oncologic outcome in patients who underwent surgical resection for multifocal ground-glass opacities (GGOs) of the lung.

Methods We examined 131 patients who underwent surgical resections for multiple clinical-N0 lung cancers. Multifocal GGOs were defined as tumors showing GGO dominance with a consolidation/tumor ratio (CTR) < 0.5 for all, whereas solid lesions were defined as having at least one tumor that showed CTR ≥0.5.

Results Multifocal GGOs were found in 53 (40.5%) patients. A significantly large number of GGOs with a median of 3 per patient (range 2–41) was observed in multifocal GGOs (p < 0.0001). A multivariate analysis demonstrated tumor size ≤ 20 mm (p = 0.0407) and multifocal GGOs (p = 0.0345) were significantly associated with the survival. Regarding surgical managements for multifocal GGOs, the 5-year overall survival (OS) of multiple synchronous or staged limited resection only (n = 26) versus anatomical resection with or without additional limited resection (n = 27) was not significantly different (100% and 91.9%, p = 0.2287). The total number of resected multifocal GGOs was 278, most of which revealed adenocarcinoma or precancerous lesions. Unresected or new GGOs developed in 19 (35.8%) patients, all of which remained pure-GGO of < 10 mm in size without any interventions. The 5-year OS of multifocal GGOs and solid lesions were 94.4% and 80.6% (p = 0.0096), with a median follow-up time of 60 months.

Conclusion Surgical interventions combined with limited surgery or adequate follow-up management based on the findings on thin-section CT could provide acceptable oncologic outcomes for multifocal GGOs.

Keywords

lung cancer - ground-glass opacity - multifocal lesions - surgery

This paper was presented at 23rd European Conference on General Thoracic Surgery, 2 June, 2015, Lisbon.

• References

• 1 Fabian T, Bryant AS, Mouhlas AL, Federico JA, Cerfolio RJ. Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg 2011; 142 (3) 547-553
• 2 Asamura H. Multiple primary cancers or multiple metastases, that is the question. J Thorac Oncol 2010; 5 (7) 930-931
• 3 Girard N, Deshpande C, Lau C , et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 2009; 33 (12) 1752-1764
• 4 Hattori A, Suzuki K, Takamochi K, Oh S. Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers?. Surg Today 2015; 45 (2) 189-196
• 5 Kim TJ, Goo JM, Lee KW, Park CM, Lee HJ. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule. Lung Cancer 2009; 64 (2) 171-178
• 6 Vazquez M, Carter D, Brambilla E , et al; International Early Lung Cancer Action Program Investigators. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009; 64 (2) 148-154
• 7 Sim HJ, Choi SH, Chae EJ , et al. Surgical management of pulmonary adenocarcinoma presenting as a pure ground-glass nodule. Eur J Cardiothorac Surg 2014; 46 (4) 632-636 , discussion 636
• 8 Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R. “Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002; 74 (5) 1635-1639
• 9 Hattori A, Suzuki K, Matsunaga T , et al. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan. Interact Cardiovasc Thorac Surg 2014; 18 (3) 329-334
• 10 Suzuki K, Koike T, Asakawa T , et al; Japan Lung Cancer Surgical Study Group (JCOG LCSSG). A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 2011; 6 (4) 751-756
• 11 Asamura H, Hishida T, Suzuki K , et al; Japan Clinical Oncology Group Lung Cancer Surgical Study Group. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg 2013; 146 (1) 24-30
• 12 Kim HK, Choi YS, Kim J, Shim YM, Lee KS, Kim K. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010; 5 (2) 206-210
• 13 Roberts PF, Straznicka M, Lara PN , et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg 2003; 126 (5) 1597-1602
• 14 Mun M, Kohno T. Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. J Thorac Cardiovasc Surg 2007; 134 (4) 877-882
• 15 Hattori A, Suzuki K, Matsunaga T , et al. Is limited resection appropriate for radiologically “solid” tumors in small lung cancers?. Ann Thorac Surg 2012; 94 (1) 212-215
• 16 Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70 (4) 606-612
• 17 Chang B, Hwang JH, Choi YH , et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013; 143 (1) 172-178
• 18 Hiramatsu M, Inagaki T, Inagaki T , et al. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth. J Thorac Oncol 2008; 3 (11) 1245-1250
• 19 Kobayashi Y, Fukui T, Ito S , et al. How long should small lung lesions of ground-glass opacity be followed?. J Thorac Oncol 2013; 8 (3) 309-314
• 20 Kodama K, Higashiyama M, Yokouchi H , et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002; 73 (2) 386-392 , discussion 392–393
• 21 Matsuguma H, Mori K, Nakahara R , et al. Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 2013; 143 (2) 436-443
• 22 Gu B, Burt BM, Merritt RE , et al. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease. Ann Thorac Surg 2013; 96 (2) 411-418
• 23 Nakata M, Sawada S, Yamashita M , et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg 2004; 78 (4) 1194-1199
• 24 Sartori G, Cavazza A, Bertolini F , et al. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis. Am J Clin Pathol 2008; 129 (2) 202-210
• 25 Takamochi K, Oh S, Matsuoka J, Suzuki K. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras. Lung Cancer 2012; 75 (3) 313-320
• 26 Yatabe Y, Mitsudomi T. Epidermal growth factor receptor mutations in lung cancers. Pathol Int 2007; 57 (5) 233-244
• 27 Yatabe Y, Borczuk AC, Powell CA. Do all lung adenocarcinomas follow a stepwise progression?. Lung Cancer 2011; 74 (1) 7-11